Department of Orthopedic Surgery, Chang Gung University College of Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, 123 Ta-Pei Road, Niao Sung Hsiang, Kaohsiung, 833, Taiwan.
Rheumatol Int. 2011 Jul;31(7):871-7. doi: 10.1007/s00296-010-1384-7. Epub 2010 Mar 16.
This study investigated the effects of shockwave on systemic concentrations of nitric oxide (NO) level, angiogenic and osteogenic and anti-inflammatory factors in hips with osteonecrosis of the femoral head (ONFH). Thirty-five patients (47 hips) with ONFH were enrolled in this study. Each hip was treated with 6,000 impulses of shockwave at 28 kV in a single session. Ten milliliters of peripheral blood was obtained for the measurements of serum NO level, angiogenic factors (VEGF, vWF, FGF basic and TGF-β1); osteogenic factors (BMP-2, osteocalcin, alkaline phosphatase, DKK-1 and IGF); and anti-inflammation markers (sICAM and sVCAM) before treatment and at 1, 3, 6 and 12 months after treatment. The hips were evaluated with clinical assessment, serial radiograph and MRI. At 12 months, the overall results showed 83% improved and 17% un-improved. Total hip was performed in 4 cases (8.5%). Serum NO3 level showed significant elevation at 1 month after treatment, but the changes at 3, 6 and 12 months were not significant. For angiogenesis, significant elevations of VEGF, vWF and FGF basic and a decrease in TGF-β1 were observed at 1 month, but the changes at 3, 6 and 12 months were non-significant. For osteogenesis, BMP-2, osteocalcin, alkaline phosphatase and IGF were significantly elevated, while DKK-1 was decreased at 1 month, but the changes at 3, 6 and 12 months were not significant. For anti-inflammation markers, significant decreases in sICAM and sVCAM were noted at 1 month after treatment, but the changes at 3, 6 and 12 months were non-significant. Local ESWT application results in significant elevations of serum NO level, angiogenic and osteogenic and anti-inflammatory factors in ONFH.
本研究探讨了冲击波对股骨头坏死(ONFH)患者系统一氧化氮(NO)水平、血管生成和骨生成及抗炎因子的影响。 本研究纳入了 35 名(47 髋)ONFH 患者。 每髋单次治疗 6000 次冲击波,冲击电压 28kV。 治疗前及治疗后 1、3、6 和 12 个月,采集外周血 10ml,检测血清 NO 水平、血管生成因子(VEGF、vWF、碱性成纤维细胞生长因子和 TGF-β1);骨生成因子(BMP-2、骨钙素、碱性磷酸酶、DKK-1 和 IGF);以及抗炎标志物(sICAM 和 sVCAM)。 通过临床评估、连续 X 线片和 MRI 对髋关节进行评估。 12 个月时,总有效率为 83%,无效 17%。 4 例(8.5%)患者行全髋关节置换术。 治疗后 1 个月血清 NO3 水平显著升高,但 3、6 和 12 个月时变化不显著。 在血管生成方面,治疗后 1 个月 VEGF、vWF、碱性成纤维细胞生长因子明显升高,TGF-β1 降低,但 3、6 和 12 个月时变化不显著。 在成骨方面,BMP-2、骨钙素、碱性磷酸酶和 IGF 明显升高,而 DKK-1 降低,3、6 和 12 个月时变化不显著。 抗炎标志物方面,治疗后 1 个月 sICAM 和 sVCAM 明显下降,但 3、6 和 12 个月时变化不显著。 局部应用 ESWT 可显著升高 ONFH 患者血清 NO 水平、血管生成和骨生成及抗炎因子。